University of Missouri Health Care is an American academic health system located in Columbia, Missouri. It is owned by the University of Missouri System.

During the past decade, University of Missouri Health Care conducted 56 clinical trials. In the 10-year time frame, 56 clinical trials started and 25 clinical trials were completed, i.e. on average, 44.6% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 16 clinical trials were completed. i.e. 51.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Missouri Health Care" #1 sponsor was "University of Missouri-Columbia" with 16 trials, followed by "Children's Oncology Group" with 10 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored, "Genzyme, a Sanofi Company" with 3 trials sponsored and "AO Innovation Translation Center" with 3 trials sponsored. Other sponsors include 57 different institutions and companies that sponsored additional 62 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Missouri Health Care" #1 collaborator was "National Cancer Institute (NCI)" with 11 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Massachusetts General Hospital" with 2 trials as a collaborator and "United States Department of Defense" with 2 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "University of Missouri Health Care" are "Leukemia" (5 trials), "Brain Tumors" (3 trials), "Burns" (3 trials), "Central Nervous System Tumors" (3 trials) and "Infection" (3 trials). Many other conditions were trialed in "University of Missouri Health Care" in a lesser frequency.

Most popular intervention types in "University of Missouri Health Care" are "Drug" (61 trials), "Biological" (14 trials), "Procedure" (10 trials), "Device" (8 trials) and "Other" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "etoposide" (7 trials), "vincristine sulfate" (6 trials), "cyclophosphamide" (5 trials) and "methotrexate" (4 trials). Other intervention names were less common.

The vast majority of trials in "University of Missouri Health Care" are 94 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "University of Missouri Health Care". undefined are not yet recruiting, 22 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 51 completed trials in University of Missouri Health Care, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in University of Missouri Health Care, 4 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 15 trials that are defined as “Not Applicable".